Exploring AI-Driven 3D Visualization in Breast Surgery at Upcoming Webinar

Upcoming Webinar on AI-Driven 3D Visualization in Breast Surgery

SimBioSys, a pioneer in AI-driven precision medicine, is teaming up with Ricoh 3D for Healthcare to present an enlightening webinar titled "AI-Powered 3D Visualization for Smarter Breast Surgery." Scheduled for December 10, 2025, at 7:00 PM ET, this live event aims to illuminate the groundbreaking clinical applications of the TumorSight™ Viz platform, which has been FDA-cleared and has transformative potential for patients and surgeons alike.

A New Era in Surgical Planning

The webinar will feature Dr. Vincent Reid, a prominent figure in the surgical community, currently serving as the Chairman of Surgery and Medical Director at the Hall Perrine Cancer Center in Mercy Cedar Rapids. Dr. Reid will share his firsthand experience of incorporating the TumorSight™ Viz technology into surgical planning, highlighting real-world case studies that have been acknowledged by major media outlets, such as ABC News Digital and Good Morning America.

Dr. Reid will be accompanied by Lexi Gormley, who is a Senior Clinical Applications Specialist at Ricoh 3D for Healthcare. Together, they will discuss the innovative capabilities of TumorSight™ Viz, under the moderation of Dr. Barry Rosen, the Chief Medical Officer at SimBioSys. This collaboration is an effort to equip physicians with the knowledge needed to integrate advanced technology into their practice, ultimately enhancing patient outcomes.

Addressing a Critical Need

In the United States, thousands of women opt for breast-conserving surgery annually. Surgeons continually seek improved tools to aid in the surgical planning process—tools that provide clarity and precision. According to Stacey Stevens, President and CEO of SimBioSys, "TumorSight™ Viz opens new pathways for surgeons to comprehend the intricacies of tumor size, shape, and its relationship with surrounding tissues. Traditional imaging methods fall short of providing this critical insight."

The TumorSight™ Viz platform uniquely converts standard breast MRI scans into intuitive, patient-specific 3D models, offering surgeons a deeper understanding of anatomy relevant to surgical feasibility. This enables more informed discussions with patients regarding their treatment options and facilitates shared decision-making in their care.

Such technological advancements are critical, as they not only elevate the standard of care but also foster more meaningful doctor-patient relationships. As Dr. Reid points out, having a clear view of the tumor's context within the breast helps surgeons assess surgical options more accurately than ever.

Commitment to Innovation

Lexi Gormley emphasizes Ricoh's dedication to advancing surgical precision through innovative technologies. The webinar serves as a valuable opportunity for breast surgeons to explore how TumorSight™ Viz integrates into everyday clinical practice. By participating, attendees will see how the platform informs surgical decision-making and enhances patient care.

This webinar is forthcoming as part of the strategic alliance between SimBioSys and Ricoh, aimed at increasing nationwide access to the TumorSight™ technology. The mounting interest around this collaboration has already been recognized on national platforms, with both companies featured for their commitment to improving breast cancer treatment through pioneering solutions.

Final Thoughts

The upcoming webinar not only showcases a significant merging of technology and healthcare but also represents a pivotal moment for breast cancer treatment. By utilizing AI-driven visualization, the medical community continues to push the boundaries of what is possible in the operating room. Clinicians interested in participating can sign up through the Ricoh 3D for Healthcare website or visit their booth at the Radiological Society of North America (RSNA) Annual Meeting currently taking place in Chicago.

SimBioSys and Ricoh 3D for Healthcare are setting the stage for the future of surgical planning and patient engagement—don't miss this chance to witness innovation in action!